Scinai Immunotherapeutics Ltd. (FRA:2F5)

Germany flag Germany · Delayed Price · Currency is EUR
0.915
+0.020 (2.23%)
Last updated: Dec 5, 2025, 9:59 AM CET
-70.86%
Market Cap 2.92M
Revenue (ttm) 976.67K
Net Income (ttm) 295.47K
Shares Out n/a
EPS (ttm) 0.22
PE Ratio 9.90
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.915
Previous Close 0.895
Day's Range 0.915 - 0.915
52-Week Range 0.730 - 4.980
Beta n/a
RSI 46.76
Earnings Date Nov 24, 2025

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson’s syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies.... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2003
Employees 31
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2F5
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.